Novel Multi-Drug Resistant Organisms
Local and national surveillance has identified novel forms of multi-drug resistant organisms (MDROs) that need to be detected and contained before they spread. Many of these organisms are difficult to treat, have been associated with international travel, and have the potential to spread rapidly.
See the Novel MDRO Reporting Flyer in the resources section for more details on how to detect and report novel MDROs. Healthcare facilities and laboratories should contact the Acute Communicable Disease Control Program immediately when any of the following organisms are detected:
Carbapenemase-producing Acinetobacter baumanii
Carbapenemase-producing Pseudomonas aeruginosa
Vancomycin-resistant Staphylococcus aureus (VRSA)
CDC Containment Strategy Responding to Emerging AR
CDC Recommendations for Identification of Candida